(3S)-3-[1-oxo-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1H-isoindol-2-yl]piperidine-2,6-dione
Structure Info
- Chemspace ID
- CSSB21511091595 (In-Stock Building Blocks)
- IUPAC Name
- (3S)-3-[1-oxo-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1H-isoindol-2-yl]piperidine-2,6-dione
- Mol formula
- C19H23BN2O5
- Mol weight
- 370 Da
- Catalog Number(s)
- 20-1160
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 1.79
- Heavy atoms count
- 27
- Rotatable bond count
- 2
- Number of rings
- 4
- Carbon bond saturation, Fsp3
- 0.526
- Polar surface area (Å)
- 85
- Hydrogen bond acceptors count
- 5
- Hydrogen bond donors count
- 1
- Zoom the structure
- CSSB21511091595
Items Overall 10 items from 2 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Abosyn Chemicals Inc. | 3 days | United States To: | 95 | 100 mg | 314.60 | |
| Abosyn Chemicals Inc. | 3 days | United States To: | 95 | 250 mg | 550.00 | |
| Abosyn Chemicals Inc. | 3 days | United States To: | 95 | 500 mg | 770.00 | |
| Abosyn Chemicals Inc. | 3 days | United States To: | 95 | 1 g | 1,078.00 | |
Description: 3-(1-oxo-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoindolin-2-yl)piperidine-2,6-dione; CAS: 2698398-71-7 | ||||||
| Abosyn Chemicals CN | 7 days | China To: | 95 | 100 mg | 314.60 | |
| Abosyn Chemicals CN | 7 days | China To: | 95 | 250 mg | 550.00 | |
| Abosyn Chemicals CN | 7 days | China To: | 95 | 500 mg | 770.00 | |
| Abosyn Chemicals CN | 7 days | China To: | 95 | 1 g | 1,078.00 | |
| Abosyn Chemicals CN | 7 days | China To: | 95 | 5 g | 2,750.00 | |
| Abosyn Chemicals CN | 7 days | China To: | 95 | 10 g | 4,527.60 | |
Description: 3-(1-oxo-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)isoindolin-2-yl)piperidine-2,6-dione; CAS: 2698398-71-7 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
![Chemical structure of 3-[1-oxo-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1H-isoindol-2-yl]piperidine-2,6-dione - CSSB03437854222](/st/structure/200/f63c653a32f0dccf02ff5d7af32dbf03/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC2CN%2528C3CCC%2528%253DO%2529NC3%253DO%2529C%2528%253DO%2529C2%253DC1.png)
![Chemical structure of 3-[1-oxo-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1H-isoindol-2-yl]piperidine-2,6-dione - CSSB02495366511](/st/structure/200/011f93f67fe84e899982b65bc5ab8ac3/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC2C%2528CN%2528C3CCC%2528%253DO%2529NC3%253DO%2529C2%253DO%2529%253DC1.png)
![Chemical structure of (3S)-3-[1-oxo-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,3-dihydro-1H-isoindol-2-yl]piperidine-2,6-dione - CSSB21511091594](/st/structure/200/be1eeefc477a73fe7c58cfec72325ac8/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC2C%2528CN%2528%255BC%2540H%255D3CCC%2528%253DO%2529NC3%253DO%2529C2%253DO%2529%253DC1.png)
![Chemical structure of N-[2-(2,6-dioxopiperidin-3-yl)-3-oxo-2,3-dihydro-1H-isoindol-5-yl]-2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]acetamide - CSSB21531608971](/st/structure/200/8f32098d36f146900ac7fb64bdb366c0/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC%2528CC%2528%253DO%2529NC2%253DCC%253DC3CN%2528C4CCC%2528%253DO%2529NC4%253DO%2529C%2528%253DO%2529C3%253DC2%2529C%253DC1.png)
![Chemical structure of [2-(2,6-dioxopiperidin-3-yl)-3-oxo-2,3-dihydro-1H-isoindol-5-yl]boronic acid - CSSB06446546318](/st/structure/200/5d5da4c19f448f60e707b74b75bbe890/OB%2528O%2529c1ccc2CN%2528C3CCC%2528%253DO%2529NC3%253DO%2529C%2528%253DO%2529c2c1.png)
![Chemical structure of N-[2-(2,6-dioxopiperidin-3-yl)-3-oxo-2,3-dihydro-1H-isoindol-5-yl]-3-fluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide - CSSB21531616176](/st/structure/200/201aa61b5569f57f86746863349e0ef4/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DC%2528C%253DC1F%2529C%2528%253DO%2529NC1%253DCC%253DC2CN%2528C3CCC%2528%253DO%2529NC3%253DO%2529C%2528%253DO%2529C2%253DC1.png)

